Tailored treatment strategies for cancer patients during COVID-19 pandemic.
Rep Pract Oncol Radiother
; 27(2): 318-330, 2022.
Article
in English
| MEDLINE | ID: covidwho-1879609
ABSTRACT
The global pandemic of respiratory disease caused by the novel human coronavirus (SARS-CoV-2) has caused indefinite global distress, uncertainty, and disturbance. This pandemic has had direct and indirect impacts for the healthcare systems across the world, but certain subgroups of patients have been particularly affected. Among these groups are patients with cancer, who as a result of their immunosuppressed status either from the disease itself or as a consequence of treatment, are at increased risk of severe COVID-19 infection and complications. The pandemic has also led to limited resources as medical services have been primarily directed to emergency care. In this context, physicians and healthcare providers have had to balance the importance of continuing treatment of cancer patients with the risk of virus infection. In this review, we outline the treatment strategies for cancer patients during this pandemic, focusing on tailored treatment in this challenging situation of varying risks and benefits.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
Rep Pract Oncol Radiother
Year:
2022
Document Type:
Article
Affiliation country:
RPOr.a2022.0024
Similar
MEDLINE
...
LILACS
LIS